This article aims to evaluate the possible effect of obesity on quality of life, psychological
status, and other clinical variables in Psoriatic arthritis (PsA). PsA patients have been …

Abnormal body mass index (BMI) was associated with worse rheumatic markers in psoriatic
arthritis (PsA) and rheumatoid arthritis (RA). Aiming to describe PsA and RA patients …

Objectives We aimed to evaluate whether obese patients with psoriatic arthritis (PsA) were
less likely to be in remission/low disease activity (LDA). Methods We used data from the …

Background Psoriatic arthritis (PsA) patients have a higher prevalence of comorbidities
including obesity, metabolic syndrome, depression and premature cardiovascular disease …

In obesity, especially if visceral, and in rheumatic diseases, the production of pro-
inflammatory cytokines contributes to an increased cardiovascular risk. Moreover, classic …

Objectives To explore the prognostic value of pre-specified comorbidities on treatment
outcomes in PsA, and to compare baseline data with cutaneous psoriasis without arthritis …

Aim The aim of this study was to compare the health‐related quality of life and functional
status of patients with psoriasis (P s), psoriatic arthritis (P s A) and control subjects. Method …

Aim: To investigate the relationship between psoriatic arthritis, severity of psoriasis and
obesity in the Turkish population. Material and methods: Patient data from psoriasis …

Obesity is a common cardiovascular risk factor in psoriatic disease. Although the prevalence
of obesity is high, the factors associated with it in patients with psoriatic arthritis (PsA) are …

Objectives To assess the quality of life (QOL) and its associated factors in patients with
psoriatic arthritis (PsA) who would start treatment with biologic drugs at the Brazilian Unified …